Walter CABRI,Patrizia MINETTI,Giovanni PIERSANTI,Giorgio TARZIA
申请号：
US14822252
公开号：
US20160002244A1
申请日:
2015.08.10
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention relates to new triazolyl purine derivatives of formula (I), processes for their preparation, and to pharmaceutical compositions containing them for the treatment of neurological disorders or cerebral ischaemia for which inhibition of adenosine A2A receptor will result at improving the health state of a patient.
